Pangalan ng Kumpanya:
Roche (Philippines) Inc.
Taon na nagsimula ang programa:
Oct 2011
Para sa anong kondisyon ito?
Cancer (Breast, Colorectal, Lung, Non-Hodgkin’s Lymphoma, and Ovarian)
Para kanino ang programa?
For patients prescribed with trastuzumab, rituximab, erlotinib, and bevacizumab.
Deskripsyon ng programa:
Roche Access for Patients (RAP) program aims to improve access to cancer patients prescribed with the Roche Oncology Brands (trastuzumab, rituximab, erlotinib, and bevacizumab). Program mechanics:
- Tiered Pricing/Differentiated discount based on economic class
- Enrolment through the attending physician
- Credit investigation component (CIBI)
- Call Center Helpdesk (provides instructions and directs patients thru the process)
- Availment of discount through an accredited sub-distributor/hospital
Saan maaaring pumunta?
Please consult and seek referral from a Medical Oncologist.
Saan tatawag para sa mga katanungan tungkol sa programa?
Please contact (02) 718-7640.